Details

Autor(en) / Beteiligte

• Navarro-Carpentieri, Daniel
• del Carmen Castillo-Hernandez, Maria
• Majluf-Cruz, Karim
• Espejo-Godinez, Guillermo
• Carmona-Olvera, Paola
• Moreno-Hernandez, Manuel
• Lugo-García, Yolanda
• Hernandez-Juarez, Jesús
• Loarca-Piña, Luis
• Isordia-Salas, Irma
• Majluf-Cruz, Abraham

Titel

Impact of Classical Risk Factors for Arterial or Venous Thrombosis in Patients With Antiphospholipid Syndrome

Ist Teil von

• Clinical and applied thrombosis/hemostasis, 2018-07, Vol.24 (5), p.834-840

Ort / Verlag

Los Angeles, CA: SAGE Publications

Erscheinungsjahr

2018

Quelle

MEDLINE

Beschreibungen/Notizen

• There are classical risk factors associated with arterial thrombosis (AT) or venous thromboembolic disease (VTD). However, less is known about these risk factors and AT or VTD episodes in patients with antiphospholipid syndrome (APS). Our aim was to elucidate whether APS-related thrombotic episodes are associated with the same risk factors as the non-APS population. We gathered demographics, medical history, complications, and causes of death associated with the risk factors for AT or VTD in patients with APS. We analyzed 677 thrombotic events in 386 patients. Type 2 diabetes mellitus and grade 3 obesity were associated with VTD instead of AT. There were no significant differences between the groups for almost all laboratory tests analyzed, although lupus anticoagulant was significantly higher in the VTD group. We suggest that thrombosis in APS is due to the APS itself and that the risks factors for AT or VTD do not have a main role. Our findings may have an ethnical background. Therefore, it may be difficult to elaborate predictive thrombotic clinical scores applicable to patients with different ethnical background.